Correspondence on 'Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement'

被引：5
作者：
Banday, Aaqib Zaffar [1 ]
Jindal, Ankur Kumar [1 ]
Singh, Surjit [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Dept Pediat, Allergy Immunol Unit, Chandigarh, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷 / 05期
关键词：
autoimmunity; immune system diseases; inflammation; therapeutics; RUXOLITINIB; EFFICACY;
D O I：
10.1136/annrheumdis-2021-219890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
[21]   Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases [J].
Edwards, Christopher J. ;
Hercogova, Jana ;
Albrand, Helene ;
Amiot, Aurelian .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (10) :1001-1014
[22]   Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders [J].
Roskoski, Robert, Jr. .
PHARMACOLOGICAL RESEARCH, 2022, 183
[23]   The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment [J].
Kim, Jin-Woo ;
Kim, Su-Young .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
[24]   Oral Peptide Therapeutics as an Emerging Treatment Modality in Immune-Mediated Inflammatory Diseases: A Narrative Review [J].
Gold, Linda Stein ;
Eyerich, Kilian ;
Merola, Joseph F. ;
Torres, Joana ;
Coates, Laura C. ;
Allegretti, Jessica R. .
ADVANCES IN THERAPY, 2025, 42 (07) :3158-3172
[25]   The bumpy road of purinergic inhibitors to clinical application in immune-mediated diseases [J].
Wyss, Matthias T. ;
Heuer, Christine ;
Herwerth, Marina .
NEURAL REGENERATION RESEARCH, 2024, 19 (06) :1206-1211
[26]   Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immune-mediated disorders: A review [J].
Kaur, Maninder ;
Singh, Manjinder ;
Silakari, Om .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 67 :434-446
[27]   Off-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases [J].
Agarwal, Aneesh ;
Diaz, Aisleen ;
Al-Dehneem, Roudha ;
Pineda, Raphaela Martina ;
Khattri, Saakshi .
JOURNAL OF DRUGS IN DERMATOLOGY, 2023, 22 (12) :1183-1190
[28]   Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay [J].
Wilkinson, Michael J. ;
Shapiro, Michael D. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44 (12) :2396-2406
[29]   Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases [J].
McNally, Jonathan P. ;
Millen, Scott H. ;
Chaturvedi, Vandana ;
Lakes, Nora ;
Terrell, Catherine E. ;
Elfers, Eileen E. ;
Carroll, Kaitlin R. ;
Hogan, Simon P. ;
Andreassen, Paul R. ;
Kanter, Julie ;
Allen, Carl E. ;
Henry, Michael M. ;
Greenberg, Jay N. ;
Ladisch, Stephan ;
Hermiston, Michelle L. ;
Joyce, Michael ;
Hildeman, David A. ;
Katz, Jonathan D. ;
Jordan, Michael B. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (24) :E4782-E4791
[30]   An updated review of infliximab biosimilar, CT-P13, in the treatment of immune-mediated inflammatory diseases [J].
Hong, Seung Wook ;
Kim, Yong-Gil ;
Ye, Byong Duk .
IMMUNOTHERAPY, 2020, 12 (09) :609-623
12345